The leading representative office of defined Corporate Investor is situated in the Guangzhou. The fund was located in Asia if to be more exact in China.
For fund there is no match between the location of its establishment and the land of its numerous investments - Canada. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Enterprise, Photography. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Lyndra Therapeutics, PingPong, ARTMS.
The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this Corporate Investor is 7 percentage points more often commits exit comparing to other companies. This GF Securities works on 22 percentage points less the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2018. When the investment is from GF Securities the average startup value is 500 millions - 1 billion dollars. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the GF Securities, startups are often financed by Yaletown Partners, Quark Venture, CTI Life Sciences Fund. The meaningful sponsors for the fund in investment in the same round are Yonghua Capital, Yaletown Partners, Suffolk Equity Partners. In the next rounds fund is usually obtained by Quark Venture, Sinowisdom, Bill & Melinda Gates Foundation.
Related Funds
Funds with similar focus
Fund Name | Location |
Allure Media | Australia, New South Wales, Sydney |
Bay Hill Capital Management | Duxbury, Massachusetts, United States |
Bayes Ventures | New York, New York, United States |
Butler University | Indiana, Indianapolis, United States |
Cantos | California, San Francisco, United States |
CK Infrastructure Holdings | China, Hong Kong, Hong Kong Island |
Commonwealth Associates | Jackson, Michigan, United States |
HSBC Mutual Fund | - |
Itoki Corporation | Japan, Osaka, Osaka Prefecture |
JCB Investments | Indiana, Seymour, United States |
Lumos Labs | California, San Francisco, United States |
Macnica Inc. | Japan, Kanagawa Prefecture, Yokohama |
NIST | Gaithersburg, Maryland, United States |
RDC - Rafael Development Corporation | Israel, Tel Aviv, Tel Aviv |
Tech Pioneers Fund | California, Menlo Park, United States |
Tianjin Bohai Leasing | China, Guangdong, Tianjin |
Turim MFO | Brazil, São Paulo, Sao Paulo |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Noematrix | 06 Sep 2024 | Shanghai, Shanghai, China | |||
Regenex Corporation | $15M | 16 Jun 2023 | - | ||
Nuwacell | 13 Sep 2022 | China, China | |||
Viiyong | $309M | 16 Aug 2022 | Shenzhen, Guangdong, China | ||
Volastra Therapeutics | $12M | 11 Feb 2020 | New York, New York, United States | ||
Pi Therapeutics | $19M | 29 May 2019 | Israel, North District, Israel | ||
Yixiaoshi Kuaixiu | $27K | 03 Feb 2018 | Yuexiu District, Guangdong Province, China | ||
Bioarray Therapeutics | $4M | 05 Oct 2017 | Boston, Massachusetts, United States | ||
Fotor | $7M | 20 Sep 2017 | Sichuan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Noematrix | 06 Sep 2024 | Shanghai, Shanghai, China | |||
Regenex Corporation | $15M | 16 Jun 2023 | - | ||
Nuwacell | 13 Sep 2022 | China, China | |||
Viiyong | $309M | 16 Aug 2022 | Shenzhen, Guangdong, China | ||
Volastra Therapeutics | $12M | 11 Feb 2020 | New York, New York, United States | ||
Pi Therapeutics | $19M | 29 May 2019 | Israel, North District, Israel | ||
Yixiaoshi Kuaixiu | $27K | 03 Feb 2018 | Yuexiu District, Guangdong Province, China | ||
Bioarray Therapeutics | $4M | 05 Oct 2017 | Boston, Massachusetts, United States | ||
Fotor | $7M | 20 Sep 2017 | Sichuan |